patented technology to grow and expand adult Stem Cells

Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place

Free
Message: CEO letter to shareholders.
Reply New Message
Prev Message Back To Forum Threaded View Next Message

It's all good! Even though we may be 2-3 years away from really getting going with production, we may see additional revenues from advance licensing deals with pharma companies who see the potential and want in on the ground floor. I like where we are and plan to buy more as funds permit...

Kirk

Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply